Nida IRP preventative maintenance and service package for the mediso nanoscan pet/CT animal imager. 02/11/2025 - 02/10/2026.

Active Purchase Order Awarded Last action

Contract number
75N95025P00093
Awardee
Awarding agency
Obligated
$67,200

Award facts

Opportunity
Contract value 40% obligated
  • $67,200.00 Current, with exercised options
  • $168,000.00 Potential, with all options
Completion date 34% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Baltimore, MD 21224, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00001 $33,600
Original award $33,600

About this award

The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, awarded a firm fixed-price purchase order to Mediso USA, LLC on February 11, 2025, for preventative maintenance and service of a Mediso NanoScan PET/CT animal imager at its Biomedical Research Center in Baltimore, Maryland. The contract carries a ceiling value of $168,000 and includes a base period from February 11, 2025, through February 10, 2026, with two additional option years extending through February 10, 2027, and a ultimate completion date of February 10, 2030. This was a non-competitive sole-source procurement, with no set-aside designation, based on the specialized nature of the equipment and the vendor's demonstrated technical capability to support this critical imaging system used in NIDA's drug abuse research.

Mediso USA, LLC, a for-profit limited liability company based in Arlington, Virginia, specializes in providing advanced medical imaging equipment and maintenance services to federal research institutions. The scope of work encompasses comprehensive preventative maintenance and customer support services to ensure continuous operational capability of the PET/CT animal imager, which is essential to NIDA's preclinical research initiatives. The award reflects NIDA's ongoing investment in maintaining sophisticated laboratory instrumentation that supports its mission to conduct research on drug abuse and addiction, with Mediso USA's established track record of federal contract performance across multiple NIH institutes demonstrating its capability to deliver the required technical expertise and responsive customer support.

Quick answers

Who was awarded contract 75N95025P00093?

75N95025P00093 was awarded to Mediso Usa, LLC by National Institute on Drug Abuse (National Institutes of Health) on February 11, 2025.

How much is contract 75N95025P00093 worth?

The government has obligated $67,200 on 75N95025P00093. Its potential value, with all options, is $168,000.

Was contract 75N95025P00093 competed?

The extent of competition for 75N95025P00093 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award